Clinical Trial Update: Study With Candida Antigen for Treatment of Warts [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating Candida antigen as a treatment for warts associated with HPV; the trial completed and posted results in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Human Papillomavirus Infection
• Verruca Vulgaris

Drugs mentioned

• Candida antigen (candida antigen)

Snippet

Sponsor: University of Arkansas | Conditions: Warts, HPV | Phase 1 | Status: COMPLETED | Results posted: 2011-01-25